HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Caboodles

This article was originally published in The Rose Sheet

Executive Summary

Sarina Godin tapped director of marketing and product development, a new position, teen cosmetics company reports July 23. Effective immediately, Godin is responsible for overseeing marketing, product development and public relations for the Caboodles, she she and C me brands, Caboodles notes. Among primary goals will be significant boost in promotional activity and review of pricing strategies, Godin notes. Exec, who will report to interim CEO Charles Beech, comes to the firm from The Color Factory, a contract design and manufacturing cosmetics company. Prior to that, she was creative director for LVMH's Hard Candy brand, for which she led effort to convey a more mature brand image (1"The Rose Sheet" Feb. 26, 2001, p. 3)...

You may also be interested in...



Hard Candy Grows Up Under Parent LVMH

Hard Candy is repositioning its brand to convey a more mature, high-fashion image following a recent shift in management involving a reduced role for founder Dineh Mohajer at the company.

Bristol/Exelixis Detail Survival Benefit For Opdivo/Cabometyx In Renal Cancer

Data show Opdivo/Cabometyx combo bests Sutent for overall and progression-free survival and response endpoints in first-line RCC. Exelixis CEO says comparison to Sutent is standard control and allows better comparison to other combo regimens.

Finance Watch: 2020 IPOs Surpass 2019 Total With 52 To Date

ES: Public Company Edition: Fifty biopharma companies launched initial public offerings in the US last year and there have been 52 so far in 2020, including Metacrine, Dyne, Athira and COMPASS.

UsernamePublicRestriction

Register

ID001014

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel